FASD
MCID: FTL006
MIFTS: 42

Fetal Alcohol Spectrum Disorder (FASD)

Categories: Fetal diseases, Mental diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Fetal Alcohol Spectrum Disorder

MalaCards integrated aliases for Fetal Alcohol Spectrum Disorder:

Name: Fetal Alcohol Spectrum Disorder 12 15
Fetal Alcohol Spectrum Disorders 52 71
Alcohol-Related Neurodevelopmental Disorder - Type 52
Alcohol-Related Birth Defects - Type 52
Fetal Alcohol Syndrome - Type 52
Fetal Alcohol Syndrome 71
Fasd 52

Classifications:



External Ids:

Disease Ontology 12 DOID:0050696
UMLS 71 C0015923 C2985290

Summaries for Fetal Alcohol Spectrum Disorder

Disease Ontology : 12 A specific developmental disorder and physical disorder that is characterized by physical, behavioral and learning birth defects resulting from maternal ingestion of alcohol during pregnancy.

MalaCards based summary : Fetal Alcohol Spectrum Disorder, also known as fetal alcohol spectrum disorders, is related to alcohol-related birth defect and alcohol-related neurodevelopmental disorder. An important gene associated with Fetal Alcohol Spectrum Disorder is BDNF (Brain Derived Neurotrophic Factor), and among its related pathways/superpathways are superpathway of tryptophan utilization and Tyrosine metabolism. The drugs Neurotransmitter Agents and Atomoxetine Hydrochloride have been mentioned in the context of this disorder. Affiliated tissues include brain, cortex and testes, and related phenotypes are growth/size/body region and craniofacial

Wikipedia : 74 Fetal alcohol spectrum disorders (FASDs) are a group of conditions that can occur in a person whose... more...

Related Diseases for Fetal Alcohol Spectrum Disorder

Diseases in the Fetal Alcohol Syndrome family:

Fetal Alcohol Spectrum Disorder

Diseases related to Fetal Alcohol Spectrum Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 182)
# Related Disease Score Top Affiliating Genes
1 alcohol-related birth defect 33.5 SLC27A5 PFAS ADH1B
2 alcohol-related neurodevelopmental disorder 33.1 PFAS PAF1 MECP2 GRIN2B
3 alcohol use disorder 32.4 SLC27A5 KDM4C H2AC18 GRIN2B CYP2E1 BDNF
4 fetal alcohol syndrome 32.3 SLC27A5 SHH PVALB PFAS PAF1 MIR9-1
5 substance abuse 31.0 SLC27A5 H2AC18 CYP2E1 BDNF ADH1B
6 alcohol dependence 30.8 GRIN2B CYP2E1 BDNF ALDH9A1 AKR1A1 ADH6
7 autism 30.7 SHH MECP2 KDM4C GRIN2B BDNF ADNP
8 autism spectrum disorder 30.5 SHH MIR140 MECP2 GRIN2B CASP3 BDNF
9 status epilepticus 30.5 PVALB GRIN2B CASP3 BDNF
10 mental depression 30.5 MIR9-1 H2AC18 GRIN2B BDNF
11 traumatic brain injury 30.3 CASP3 BDNF
12 orofacial cleft 30.3 SHH MIR140 KDM4C H2AC18
13 fragile x syndrome 30.2 MIR9-1 MECP2 H2AC18 GRIN2B BDNF
14 disease of mental health 30.2 PVALB MIR9-1 MIR140 MECP2 KDM4C H2AC18
15 psychotic disorder 30.2 PVALB MIR9-1 H2AC18 GRIN2B BDNF
16 rett syndrome 30.1 MECP2 L1CAM H2AC18 BDNF
17 pervasive developmental disorder 29.7 PVALB MIR9-1 MIR140 MECP2 KDM4C H2AC18
18 partial fetal alcohol syndrome 11.7
19 attention deficit-hyperactivity disorder 10.6
20 neonatal hypoxic and ischemic brain injury 10.6 PVALB BDNF
21 non-syndromic intellectual disability 10.5 MIR9-1 H2AC18 ADNP
22 methanol poisoning 10.5 CYP2E1 AKR1A1 ADH1B
23 occlusion precerebral artery 10.5 GRIN2B CASP3 BDNF
24 lymphatic system cancer 10.5 MIR140 KDM4C H2AC18
25 alcoholic cardiomyopathy 10.5 CYP2E1 ADH6 ADH1B
26 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 10.5
27 mature b-cell neoplasm 10.5 MIR9-1 KDM4C H2AC18
28 kleefstra syndrome 1 10.5 MECP2 KDM4C H2AC18
29 drug dependence 10.5 BDNF ADH6 ADH1B
30 bile duct adenocarcinoma 10.4 MIR9-1 MIR140 KDM4C H2AC18
31 retinitis pigmentosa 11 10.4 SLC27A5 KDM4C H2AC18
32 alcoholic liver cirrhosis 10.4 CYP2E1 AKR1A1 ADH1B
33 bile duct disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
34 biliary tract disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
35 overnutrition 10.4 MIR9-1 MIR140 KDM4C H2AC18
36 autosomal genetic disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
37 chromosomal deletion syndrome 10.4 MIR9-1 MECP2 H2AC18
38 bladder disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
39 chromosome 16p13.3 deletion syndrome, proximal 10.4 MIR9-1 MECP2 KDM4C H2AC18
40 pancreas disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
41 colonic disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
42 alacrima, achalasia, and mental retardation syndrome 10.4
43 retinal cancer 10.4 MIR9-1 KDM4C H2AC18 CASP3
44 gonadal disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
45 chromosomal disease 10.4 MIR9-1 MECP2 H2AC18 BDNF
46 x-linked monogenic disease 10.4 MIR9-1 MECP2 H2AC18 BDNF
47 male reproductive organ cancer 10.4 MIR9-1 MIR140 KDM4C H2AC18
48 male reproductive system disease 10.4 MIR9-1 MIR140 KDM4C H2AC18
49 infratentorial cancer 10.4 SHH MIR9-1 KDM4C H2AC18
50 reproductive system disease 10.4 MIR9-1 MIR140 KDM4C H2AC18

Graphical network of the top 20 diseases related to Fetal Alcohol Spectrum Disorder:



Diseases related to Fetal Alcohol Spectrum Disorder

Symptoms & Phenotypes for Fetal Alcohol Spectrum Disorder

MGI Mouse Phenotypes related to Fetal Alcohol Spectrum Disorder:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.93 AKR1A1 BDNF CASP3 CYP2E1 GRIN2B KDM4C
2 craniofacial MP:0005382 9.86 AKR1A1 BDNF CASP3 CYP2E1 L1CAM MECP2
3 mortality/aging MP:0010768 9.77 ADNP AKR1A1 BDNF CASP3 CYP2E1 GRIN2B
4 no phenotypic analysis MP:0003012 9.23 BDNF CASP3 GRIN2B KDM4C L1CAM MECP2

Drugs & Therapeutics for Fetal Alcohol Spectrum Disorder

Drugs for Fetal Alcohol Spectrum Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Neurotransmitter Agents Phase 3
2 Atomoxetine Hydrochloride Phase 3
3 Adrenergic Agents Phase 3
4
Choline Approved, Nutraceutical Phase 2 62-49-7 305
5 Gastrointestinal Agents Phase 2
6 Hypolipidemic Agents Phase 2
7 Nootropic Agents Phase 2
8 Lipid Regulating Agents Phase 2
9 Antimetabolites Phase 2
10 Central Nervous System Depressants Phase 2
11 Anti-Infective Agents, Local Phase 2
12 Anti-Infective Agents Phase 2
13
tannic acid Approved 1401-55-4
14
Benzocaine Approved, Investigational 1994-09-7, 94-09-7 2337
15
Nicotine Approved 54-11-5 942 89594
16
Ethanol Approved 64-17-5 702
17
Nitric Oxide Approved 10102-43-9 145068
18
leucovorin Approved 58-05-9 6006 143
19
Folic acid Approved, Nutraceutical, Vet_approved 59-30-3 6037
20
Epigallocatechin Experimental, Investigational 970-74-1 72277
21
Epigallocatechin gallate Investigational 989-51-5 65064
22 Antioxidants
23 Protective Agents
24 Neuroprotective Agents
25 Vitamins
26 Trace Elements
27 Micronutrients
28 Nutrients
29 Hematinics
30 Vitamin B Complex
31 Vitamin B9
32 Folate
33 Tetrahydrofolates

Interventional clinical trials:

(show all 50)
# Name Status NCT ID Phase Drugs
1 An Open-label Study of the Long Term Tolerability and Safety of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal-Alcohol Syndrome or Effects. Completed NCT00418262 Phase 3 Atomoxetine
2 Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders Completed NCT01911299 Phase 2
3 Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Completed NCT01149538 Phase 1, Phase 2 Choline bitartrate
4 Fetal Alcohol Syndrome/ARND Research Consortion-Oklahoma Completed NCT00164554 Phase 1, Phase 2
5 Neurocognitive Habilitation for Children With FAS/ARND Completed NCT00164346 Phase 1, Phase 2
6 Study to Investigate the Effectiveness of a Math Intervention for Children With Fetal Alcohol Syndrome or Related Condition Completed NCT00164229 Phase 1, Phase 2
7 A Media Based Motivational Intervention to Reduce Alcohol Exposed Pregnancies (AEPs) Completed NCT00219336 Phase 2
8 Project CHOICES Efficacy Study for Preventing Alcohol-Exposed Pregnancies Completed NCT00153478 Phase 2
9 Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Recruiting NCT02735473 Phase 2 Choline bitartrate;Placebo
10 Neighborhood Alcohol & HIV Prevention in South African Townships (Philani) Active, not recruiting NCT00996528 Phase 2
11 A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects Completed NCT00417794 Phase 1 Strattera;Placebo
12 Computer-delivered SBIRT for Alcohol Use in Pregnancy: Planning a Stage II Trial Completed NCT01643044 Phase 1
13 Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology Unknown status NCT02759874
14 Effects of Hyperbaric Oxygen Therapy on Cognitive Function on Autistic Spectrum Disordered Children Unknown status NCT00631215
15 Strongest Families FASD: Parent Training for Challenging Behaviour in Children With Fetal Alcohol Spectrum Disorder (FASD) Completed NCT02210455
16 Evaluating the Effectiveness of an Attachment-Focused Intervention in Preschool Children With Fetal Alcohol Spectrum Disorder (FASD) or At-risk for FASD: A Randomized Controlled Field Trial Completed NCT01536184
17 Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention Completed NCT02457676
18 Neuromodulation Augmented Cognitive Remediation to Improve Executive Dysfunction in Fetal Alcohol Spectrum Disorder (FASD) Completed NCT03361293
19 Development of Education Materials for Prevention of Fetal Alcohol Syndrome (FAS) in Russia Completed NCT01971398
20 "Brief Alcohol Intervention: The Healthy Moms Project." Completed NCT00244062
21 Self-Regulation in Adolescents With FASD: The Efficacy of a Targeted Intervention Completed NCT02912962
22 Reducing Alcohol Exposed Pregnancy Risk Completed NCT01446653
23 Dog-Assisted Therapy for Children and Adolescents With FASD: a Randomized Controlled Pilot Study Completed NCT04038164
24 Preventing FAS/ARND in Russian Children Completed NCT01961050
25 Prevention of Fetal Alcohol Damage Using Maternal Blood Markers Completed NCT00696085
26 A Randomized Clinical Trial of the Contraception and Alcohol Risk Reduction Internet Intervention to Reduce AEP Risk in Community Women Completed NCT02128880
27 Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women Completed NCT01994603
28 Comprehensive Program for Youth Mental Health Completed NCT02169960
29 Epigallocatechin Gallate (EGCG) as Therapeutic Tool to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children Completed NCT02558933
30 Early Identification of Affected Children and Nutritional Risk Factors for FASD in Ukraine Completed NCT03782935
31 Modeling and Testing Change in Mental Abilities in Childhood Through Computer-based Interventions Completed NCT02459873
32 Effects of Hyperbaric Oxygen Therapy on Clinical Symptoms and Markers of Inflammation and Oxidative Stress in Autistic Children: A Pilot Study Completed NCT00324909 Hyperbaric Oxygen Therapy
33 Face Anthropometric Pattern Recognition Technology, Based on 3D Reconstruction Technology, for Computer Aided Diagnosis of Human Genetic Disorders. Multicenter Collaborative Study. Completed NCT00705055
34 A Prospective, Randomized, Double-Blind, Controlled Study on the Clinical Effects of Hyperbaric Therapy in Autistic Children Completed NCT00335790
35 Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder Recruiting NCT03494738
36 Dissecting the Genetics of Fetal Alcohol Spectrum Disorders Recruiting NCT04072809
37 In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions Recruiting NCT03371641
38 Fetal Alcohol Spectrum Disorder-Is This a Ciliopathy? Recruiting NCT03802708
39 The Trajectory of Fetal Alcohol Spectrum Disorders (FASD) Across the Life Span: Continuing Prevention and Longitudinal Epidemiology Recruiting NCT04026620
40 Parent Emotion Socialization and Child Emotion Regulation in FASD Recruiting NCT03524664
41 Newborn Phosphatidylethanol Screening to Detect Fetal Alcohol Exposure in Uruguay Recruiting NCT02600624
42 Native-Changing High-risk Alcohol Use and Increasing Contraception Effectiveness Study Recruiting NCT03930342
43 Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial Recruiting NCT03342495
44 The Effectiveness of an Educational Program on Parenting Stress and Coping Mechanism Among Parents of Children With Autism Spectrum Disorder in Amman, Jordan Recruiting NCT03805828
45 Food and Alcohol Behavior Study: Meaningful Enhancement Recruiting NCT04095052
46 Behavioral Exploration of Cognitive and Emotional Alterations in Adult Individuals Exposed to Alcohol During the Prenatal Period Active, not recruiting NCT03793920
47 Feasibility Trial of the FMF Connect Mobile Health Intervention Not yet recruiting NCT04194489
48 CHILD-BRIGHT READYorNot[TM] Brain-Based Disabilities Trial Not yet recruiting NCT03852550
49 Development, Implementation, and Evaluation of an Internet-based Behavioural Sleep Intervention for Children With NDD and Insomnia Not yet recruiting NCT02694003
50 Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome Terminated NCT00747630 Early Phase 1

Search NIH Clinical Center for Fetal Alcohol Spectrum Disorder

Genetic Tests for Fetal Alcohol Spectrum Disorder

Anatomical Context for Fetal Alcohol Spectrum Disorder

MalaCards organs/tissues related to Fetal Alcohol Spectrum Disorder:

40
Brain, Cortex, Testes, Eye, Cerebellum, Fetal Brain, Prefrontal Cortex

Publications for Fetal Alcohol Spectrum Disorder

Articles related to Fetal Alcohol Spectrum Disorder:

(show top 50) (show all 1589)
# Title Authors PMID Year
1
Developmental stage and genotype dependent behavioral effects of embryonic alcohol exposure in zebrafish larvae. 61
31655157 2020
2
The best possible start: A qualitative study on the experiences of parents of young children with or at risk for fetal alcohol spectrum disorders. 61
31884315 2020
3
Family reflections: fetal alcohol spectrum disorders. 61
32028526 2020
4
Recent developments in fetal alcohol spectrum disorder. 61
31789722 2020
5
Early Postnatal Ethanol Exposure in Mice Induces Sex-Dependent Memory Impairment and Reduction of Hippocampal NMDA-R2B Expression in Adulthood. 61
31874240 2020
6
Unisensory and Multisensory Responses in Fetal Alcohol Spectrum Disorders (FASD): Effects of Spatial Congruence. 61
31982473 2020
7
Hydrogen Sulfide Attenuates the Neurotoxicity in the Animal Model of Fetal Alcohol Spectrum Disorders. 61
31900896 2020
8
Neurodevelopmental Outcomes Associated with Prefrontal Cortical Deoxygenation in Children with Fetal Alcohol Spectrum Disorders. 61
31914808 2020
9
Fetal Alcohol Spectrum Disorders: Health Needs Assessment in Brazil. 61
31984499 2020
10
Prenatal Alcohol Exposure Alters Error Detection During Simple Arithmetic Processing: An Electroencephalography Study. 61
31742737 2020
11
Community-based child development service fetal alcohol spectrum disorder assessment: A retrospective clinic audit. 61
31944476 2020
12
Ophthalmological findings in fetal alcohol spectrum disorders - a cohort study from childhood to adulthood. 61
31926885 2020
13
Medicinal Use of Cannabis in Children and Pregnant Women. 61
32017681 2020
14
Neurodevelopment in adolescents and adults with fetal alcohol spectrum disorders (FASD): A magnetic resonance region of interest analysis. 61
31930998 2020
15
Self-care in caregivers of children with FASD: How do caregivers care for themselves, and what are the benefits and obstacles for doing so? 61
32014800 2020
16
Novel Ethanol-Sensitive Mutants Identified in an F3 Forward Genetic Screen. 61
31742718 2020
17
Prenatal Ethanol Exposure Leads to Attention Deficits in Both Male and Female Rats. 61
32038156 2020
18
The Impact of Paternal Alcohol Consumption on Offspring Brain and Behavioral Development. 61
31746471 2020
19
Professionals' accounts of genetic testing in adoption: a qualitative study. 61
31296598 2020
20
Lasting alterations induced in glial cell phenotypes by short exposure to alcohol during embryonic development in zebrafish. 61
31919968 2020
21
Disability "In-Justice": The Benefits and Challenges of "Yarning" With Young People Undergoing Diagnostic Assessment for Fetal Alcohol Spectrum Disorder in a Youth Detention Center. 61
31691628 2020
22
Maternal adverse childhood experiences are associated with binge drinking during pregnancy in a dose-dependent pattern: Findings from the All Our Families cohort. 61
31896532 2019
23
Prenatal Ethanol Exposure and Postnatal Environmental Intervention Alter Dopaminergic Neuron and Microglia Morphology in the Ventral Tegmental Area During Adulthood. 61
31872887 2019
24
Morphological changes of the dorsal contour of the corpus callosum during the first two years of life. 61
31840188 2019
25
Modification of stem cell states by alcohol and acetaldehyde. 61
31846616 2019
26
Programmed increases in LXRα induced by paternal alcohol use enhance offspring metabolic adaptation to high-fat diet induced obesity. 61
31767168 2019
27
Medicinal Use of Cannabis in Children and Pregnant Women. 61
31826800 2019
28
Radiological Findings on Structural Magnetic Resonance Imaging in Fetal Alcohol Spectrum Disorders and Healthy Controls. 61
31840819 2019
29
Children with Fetal Alcohol Syndrome (FAS): 3D-Analysis of Palatal Depth and 3D-Metric Facial Length. 61
31877770 2019
30
Two case reports of fetal alcohol syndrome: broadening into the spectrum of cardiac disease to personalize and to improve clinical assessment. 61
31856879 2019
31
Comparing Executive Functioning in Children and Adolescents With Fetal Alcohol Spectrum Disorders and ADHD: A Meta-Analysis. 61
26729621 2019
32
Association of adverse childhood experiences and neurodevelopmental disorders in people with fetal alcohol spectrum disorders (FASD) and non-FASD controls. 61
31842817 2019
33
Spatial Navigation in Children and Young Adults with Fetal Alcohol Spectrum Disorders. 61
31593324 2019
34
Fetal Alcohol Spectrum Disorders in a Pacific Southwest City: Maternal and Child Characteristics. 61
31688971 2019
35
Early Detection of Fetal Alcohol Spectrum Disorders: An Elusive but Critical Goal. 61
31744892 2019
36
Proceedings of the 2018 annual meeting of the Fetal Alcohol Spectrum Disorders study group. 61
31173861 2019
37
Ocular fetal alcohol spectrum disorders. 61
31879141 2019
38
Early-Life Predictors of Fetal Alcohol Spectrum Disorders. 61
31744890 2019
39
Alterations in the whole brain network organization after prenatal ethanol exposure. 61
31855302 2019
40
The cost-effectiveness of screening tools used in the diagnosis of fetal alcohol spectrum disorder: a modelled analysis. 61
31881876 2019
41
[Fetal alcohol exposure: when placenta would help to the early diagnosis of child brain impairments]. 61
31845877 2019
42
Tooth Malformations, DMFT Index, Speech Impairment and Oral Habits in Patients with Fetal Alcohol Syndrome. 61
31717945 2019
43
Animal models of gene-alcohol interactions. 61
31774246 2019
44
Prenatal and postnatal alcohol exposure increases vulnerability to cocaine addiction in adult mice. 61
31705540 2019
45
Caregiver and family quality of life for children with fetal alcohol spectrum disorder. 61
31476724 2019
46
Maternal Iron Nutriture Modulates Placental Development in a Rat Model of Fetal Alcohol Spectrum Disorder. 61
31734307 2019
47
Multivariate models of brain volume for identification of children and adolescents with fetal alcohol spectrum disorder. 61
31737980 2019
48
A guideline for the prevention and management of Fetal Alcohol Spectrum Disorder in South Africa. 61
31694624 2019
49
Quantifying fetal alcohol exposure by meconium fatty acid ethyl esters (FAEE); association with adverse fetal outcomes and population estimates of fetal alcohol exposure. 61
31595802 2019
50
Impaired Bidirectional Synaptic Plasticity in Juvenile Offspring Following Prenatal Ethanol Exposure. 61
31386206 2019

Variations for Fetal Alcohol Spectrum Disorder

Expression for Fetal Alcohol Spectrum Disorder

Search GEO for disease gene expression data for Fetal Alcohol Spectrum Disorder.

Pathways for Fetal Alcohol Spectrum Disorder

GO Terms for Fetal Alcohol Spectrum Disorder

Cellular components related to Fetal Alcohol Spectrum Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytoplasm GO:0005737 9.47 PVALB PFAS PAF1 MIR9-1 MECP2 GRIN2B

Biological processes related to Fetal Alcohol Spectrum Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxidation-reduction process GO:0055114 9.17 SLC27A5 KDM4C CYP2E1 ALDH9A1 AKR1A1 ADH6
2 ethanol oxidation GO:0006069 9.16 ADH6 ADH1B
3 cellular aldehyde metabolic process GO:0006081 8.96 ALDH9A1 AKR1A1

Molecular functions related to Fetal Alcohol Spectrum Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxidoreductase activity GO:0016491 9.17 SLC27A5 KDM4C CYP2E1 ALDH9A1 AKR1A1 ADH6
2 alcohol dehydrogenase activity, zinc-dependent GO:0004024 9.16 ADH6 ADH1B
3 retinol dehydrogenase activity GO:0004745 9.13 AKR1A1 ADH6 ADH1B

Sources for Fetal Alcohol Spectrum Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....